A polypeptide of 8500 molecular weight is described that induces the differentiation of T (thymusderived) cell and B (bone-marrow-derived) cell immunocytes in vitro, apparently via fl-adrenergic receptors and adenylate cyclase activation. This polypeptide shows a high degree of evolutionary conservation, exhibiting close structural, functional, and immunological similarity when isolated from such diverse origins as cells of mammals and higher plants. This polypeptide was detected in animal cells, yeast, bacteria, and higher plants, and so may well be a universal constituent of living cells.
The isolation from bovine thymus of the polypeptide hormones thymopoietin I and II has been described previously (1 2) . [ We are now using the term thymopoietin (3) because valid objections (4) were raised to our previous term "thymin," which is easily confused with the pyrimidine base thymine. ] Pure thymopoietin I and II specifically induce prothymocytes to differentiate into thymocytes (5) (6) (7) , but these polypeptides were recognized originally not by this evidently physiological faculty of T (thymus-derived) cell differentiation but by a presumably incidental property discovered in the course of studies related to the human disease myasthenia gravis, in which a characteristic neuromuscular disturbance is consistently associated with thymic pathology. When reliable assays of T-cell differentiation in vitro became available, based on the manifestation of T-cell antigens on precursor cells (5, 8) it was realized that, although certain pure thymic products (thymopoietins) could induce this step in T-cell differentiation specifically, extracts of tissues other than thymus were also active (10) .
We describe here the isolation and purification from bovine thymus of a polypeptide subsequently detected in many other tissues, which like thymopoietin induces the differentiation of pro-thymocytes, but which unlike thymopoietin induces differentiation of B (bone-marrow-derived) cells, and is thus distinguished in its mode of action from the physiological inducer thymopoietin. This Fig. 1 were lyophilized and rerun on the same column. The lyophilized fractions from this column were then fractionated by adsorption chromatography on hydroxyapatite (Bio-Rad). A 500-mg load was dissolved in 5 mM sodium phosphate buffer, pH 6.8, and applied on a 2.5 X 30-cm column of hydroxyapatite in the same buffer. Thymopoietin eluted behind the void volume with 5 mM phosphate buffer; subsequently the concentration of the eluting buffer was raised to 50 mM. The fractions shown in Fig. 1 Induction of T-cell and B-cell differentiation by UBIP UBIP causes no neuromuscular lesion detectable in the electromyographic assay originally used to monitor the isolation of thymopoietin. UBIP did, however, induce the differentiation of immunocyte precursors in vitro, although the following data show that activity in this respect is clearly distinguishable from that of thymopoietin.
The differentiation of pro-thymocytes to thymocytes was assayed by the acquisition of the thymic differentiation antigen TL (thymus leukemia) (5, 8) using the KomuroBoyse assay in which the induced (now TL+) cells are lysed on exposure to TL antiserum and complement in the cytotoxicity test (8) . The differentiation of B cells was measured under similar conditions in vitro. In the experiments reported here the acquisition of receptors for complement (CR) was used as an index of B-cell differentiation (7, 11) ; the precursor B cells were derived from fractionated mouse spleen cells as in the case of pro-thymocytes.
We recognize that these T-cell and B-cell differentiation assays are not strictly comparable because TL conversion and acquisition of C3 receptors are not strictly equivalent events in the sequence of T-cell and B-cell maturation. Nevertheless the CR-to CR+ conversion is a clearly defined step in B-cell differentiation as is the TL-to TL+ conversion of the prothymocyte. Other markers for sequential events in the B cell differentiation (surface Ig-to Ig+, or acquisition of B-cell surface antigens) can equally be employed, and we have done so; use of the CR criterion in this study was a matter of convenience.
The results are summarized in Table 1 . UBIP induced in vitro the differentiation of pro-thymocytes (14% cells induced to express TL at 1 ng/ml) and pro-B cells (10% cells induced to express CR at 1 ng/ml). By contrast, thymopoietin induced pro-thymocyte differentiation (13% cells induced to express TL at 1 ng/ml) but had no effect on pro-B cells (no significant induction of CR+ cells at 1, 10, and 100 ng/ml).
A further contrast between the inductive potentials of thymopoietin and UBIP is revealed by propranolol, which blocks ,B-adrenergic receptors. We know that the inductive potential of crude tissue extracts of thymus or other organs on both T cell and B cell differentiation can be blocked by propranolol (7). Propranolol, 10 ,M, also blocked both T-cell and B-cell differentiation by UBIP, whereas the induction of T-cell differentiation by thymopoietin was not affected ( Table  1 ), signifying that the initiating step by the specific (thymopoietin) and nonspecific (UBIP) inducers is dissimilar.
Representation of UBIP in cells of diverse origins UBIP isolated from thymic extracts was studied in the first instance because it is the major polypeptide component in the 4,000 to 12,000 molecular weight range and, therefore, it seemed quite likely to be a thymic hormone in some form. We see that this is not so. Unlike thymopoietin, which is detectable only in thymus extracts and not extracts of other tissues (2, 12) , UBIP has been detectable by disc electrophoresis with polyacrylamide gels in extracts from all guinea pig tissues tested (Fig. 3) . Differentiation of immunocyte precursors in vitro induced by thymopoietin I or UBIP, according to the criteria of TLantigen expression (T cells) and of expression of complement receptors (B cells). Spleen cells from A or congenic A/TL-mice were fractionated on bovine serum albumin gradients as described previously (8) and induction of cytotypic markers was studied in the B layer (23-26% interface), which was found to contain both the pro-thymocytes and immature B cells. TL induction was measured by the direct cytotoxic test with anti-TL antibody and complement as described previously (8) . Induction of complement receptors was measured by the formation of rosettes with EAC sheep erythrocytes coated with subagglutinating quantities of rabbit antibody to sheep erythrocytes plus nonlytic complement (11) . Before induction the complement receptor lymphocytes (CRL) in spleen were first depleted by forming rosettes as in the standard assay (I1) and removing them by differential centrifugation; this was achieved by the 2-step bovine serum albumin gradient described by Bianco ct al. (11) (free lymphocytes being collected at the 10-35% interface) or by low-speed centrifugation (free lymphocytes remaining in the supernatant). The CRLdepleted population was further enriched for B precursor cells by fractionation on a discontinuous 5-step serum albumin gradient (8) which gives an optimal yield at the 23-26% interface. This cell fraction was incubated with or without polypeptide for 2 hr and afterwards scored for CR+ cells according to Bianco et al. (11) . * Mean ± SEM. Data represent summary of four experiments.
Calculated from [(a -b)/a] X 100 where a = % negative cells after incubation without polypeptide, and b = % negative cells after incubation with polypeptide. Fig. 5 shows that a single peak of UBIP could be registered by radioimmunoassay in calf thymus homogenate fractioned by molecular sieve chromatography on Sephadex G-50. Thus, the numerous other substances in this extract did not compete with '25I-labeled UBIP for the anti-UBIP antibody. Further specificity controls are shown in Table 2 . Most proteins or polypeptides tested showed no detectable UBIP (<0.001%) or trivial amount (0.002-0.01%). Only ribonuclease B appeared to contain a significant amount of UBIP (0.1-1%). Contamination with UBIP rather than cross reactivity is the more likely explanation because two batches of ribonuclease B gave a 10-fold difference. Also, although in the case of the ribonuclease B sample with 1% UBIP the ribonuclease B band ran with the same mobility as UBIP in polyacrylamide gel electrophoresis at pH 4.3, the ribonuclease ran distinctly slower at pH 8.9, and a faster band with the mobility of UBIP was clearly stained.
This highly specific radioimmunoassay for UBIP was then Table 3 . The widespread occurrence of UBIP in mammalian tissues indicated by disc electrophoresis on polyacrylamide gels was confirmed. UBIP was present in the tissues of (nu/nu) mice, which have no thymus, mammalian tumor cell lines, fibroblasts, various cells maintained in culture, and avian embryos and fibroblasts in culture; The phylogenetic pedigree of UBIP according to the radioimmunoassay suggests that UBIP is perhaps ubiquitous in living cells, because it is found not only in fish and a nonvertebrate but also in higher plants, yeasts, and bacteria (Table 3) . A small quantity of UBIP was isolated from celery, as representing a phylogenetic source extremely distant from mammals. The isolation methods were as for bovine UBIP except that the celery was initially homogenized in a domestic "juicer" and centrifuged, the heating step was omitted, and the position of celery UBIP on CM-Sephadex chromatography was determined by radioimmunoassay because the amounts recovered were too small to produce a detectable peak of ultraviolet absorbance.
Amino-acid sequence at the N-terminus was determined by sequential Edman degradation on an automated sequencer as described (16) . There is a remarkable conservation of aminoacid sequence in UBIP, six of the first eight residues being identical in bovine and celery UBIP (Fig. 6 ). This work was done on a small amount of material and it must be confirmed and extended.
Additional evidence for structural conservation comes from the radioimmunoassay, in which the binding-inhibition curve of celery UBIP is very similar to that of human and bovine UBIP (Fig. 4) . Functional tests provide further evidence of conservation. Celery UBIP, like bovine UBIP, induced in vitro the differentiation of mouse pro-thymocytes (9% induction of TL+ cells) and B cells (16% induction of CR+ cells), and both effects were inhibited by 10 IAM propranolol (<2% induction of TL+ and CR+ cells).
Biological significance of UBIP As we have pointed out, the recognition of UBIP was incidental to a study on the thymus which had a quite different objective. But the properties and remarkable phylogenetic conservation of this polypeptide raise general points that are worthy of note.
Thymopoietin induces in vitro the differentiation of prothymocytes to thymocytes. This induction, evidently mediated via cAMP (7), is specific for thymocyte differentiation, since thymopoietin has no demonstrable effect on the differentiation of B cells (6, 7) , erythropoietin-sensitive cells (6) , or pluripotent hemopoietic stem cells (6) weight. The yeasts and bacteria, which were obtained lyophilized, were first suspended and washed in the buffer to remove any remaining nutrient medium. After washing, the pellet was resuspended and homogenized in the presence of glass beads to disrupt cells. After centrifugation the supernatant was tested in the radioimmunoassay as above. The amount of UBIP for these is expressed asug/g of dry weight.
tiative steps concern the triggering of pt-programmed or "committed" precursors.
The finding that UBIP, a potent inducer of immunocyte differentiation, is widespread and perhaps ubiquitous in cells of all kinds emphasizes the crucial role of specificity controls in the studies of physiological differentiation or induction of any kind, not least in experimental embryology, where the long search for specific inducers has been hampered by positive results with incongruous tissues or other materials (17) (18) (19) (20) .
Although UBIP is a potent inducer of immunocyte differentiation in vitro, it is unlikely to have such a function in vivo. Athymic (nu/nu) mice have plentiful pro-thymocytes and they characteristically lack T cells, but their tissues contain normal quantities of UBIP.
What, then, is the physiologic function of UBIP, since UBIP from such phylogenetically disparate sources as mammals and plants shows such uniformity by structural, functional, and immunological criteria? That UBIP should have been so rigorously conserved throughout this immense evolutionary time-span suggests a function vital to the living organism. As UBIP is present in bacteria, its function clearly antedates even such early evolutionary steps as karyon formation, let alone the cellular organization of metazoa and intercellular regulation by nerve networks and endocrine-receptor signals. UBIP activates adenylate cyclase in a wide variety of tissues (M. W. Bitensky and G. Goldstein, in preparation), and it may function physiologically as an essential element of this basic mechanism, since adenylate cyclase is also very widely represented in animals, plants, and unicellular organisms (21) .
However that might be, we can infer that the function of UBIP is an integral feature of living cells. The nature of that basic function is unknown, and this provides a question that may have intrinsic importance in its own right. Likewise, the way in which UBIP triggers pre-programmed immunocytes and doubtless other committed cells remains to be elucidated in detail. This itself may be of considerable value in further studies of differentiative-inductive processes generally (20) .
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